Literature DB >> 7011759

Specific antibodies and Fab fragments to alter the pharmacokinetics and reverse the pharmacologic/toxicologic effects of drugs.

W A Colburn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7011759     DOI： 10.3109/03602538008994026

Source DB:  PubMed          Journal:  Drug Metab Rev        ISSN： 0360-2532            Impact factor:   4.518


× No keyword cloud information.
  4 in total

Review 1.  Vaccines against nicotine: how effective are they likely to be in preventing smoking?

Authors:  F J Vocci; C N Chiang
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

2.  Population pharmacokinetics and pharmacodynamics of the anti-CD11a antibody hu1124 in human subjects with psoriasis.

Authors:  R J Bauer; R L Dedrick; M L White; M J Murray; M R Garovoy
Journal:  J Pharmacokinet Biopharm       Date:  1999-08

3.  Monoclonal digoxin-specific antibodies induce dose- and affinity-dependent plasma digoxin redistribution in rats.

Authors:  N J Cano; A E Sabouraud; K Benmoussa; F Roquet; I Navarro-Teulon; J C Mani; J M Scherrmann
Journal:  Pharm Res       Date:  1995-05       Impact factor: 4.200

4.  Increasing the potency of neutralizing single-domain antibodies by functionalization with a CD11b/CD18 binding domain.

Authors:  Martin A Rossotti; Andrés González-Techera; Julio Guarnaschelli; Lucia Yim; Ximena Camacho; Marcelo Fernández; Pablo Cabral; Carmen Leizagoyen; José A Chabalgoity; Gualberto González-Sapienza
Journal:  MAbs       Date:  2015       Impact factor: 5.857
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.